Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Does Eli Lilly Miss the Grade?
Motley Fool
Tuesday, July 26, 2011 - 4:30pm
tags:
Eli Lilly
Biogen Earnings: Tysabri Sales Impress
TheStreet.com
Tuesday, July 26, 2011 - 1:59pm
tags:
Biogen Idec, earnings
Ligand trades higher on study of Promacta drug
Yahoo/AP
Tuesday, July 26, 2011 - 1:54pm
tags:
Promacta, Ligand, GSK, hepatitis C
Glaxo’s Product Pipeline Needs Priming
WSJ Online
Tuesday, July 26, 2011 - 1:40pm
tags:
GSK, pipelines, patents
Earnings Preview: Mylan Inc.
Yahoo/Zacks.com
Tuesday, July 26, 2011 - 11:10am
tags:
earnings, Mylan
Watson Pharmaceuticals 2Q profit dips 25 percent
Yahoo/AP
Tuesday, July 26, 2011 - 10:44am
tags:
Watson Pharmaceuticals, earnings
GlaxoSmithKline cost-cutting drives $1.8 billion profit in second quarter; Japan sales strong
Yahoo/AP
Tuesday, July 26, 2011 - 10:42am
tags:
GSK, earnings
Specialty Drugs Entice BTG While Awaiting Varicose-Vein Medicine
Bloomberg
Tuesday, July 26, 2011 - 10:40am
tags:
varicose vein, BTG
Conflict-of-Interest Rules May Be Relaxed in 2012, Hamburg Says
Bloomberg
Monday, July 25, 2011 - 7:40pm
tags:
FDA, conflict-of-interest, Peggy Hamburg, physician payments
Pharmasset research costs climb in 3Q loss
Yahoo/AP
Monday, July 25, 2011 - 7:38pm
tags:
Pharmasset, earnings
Bristol-Myers' Acquisition Could Pay for Itself
Motley Fool
Monday, July 25, 2011 - 7:37pm
tags:
M&A, Bristol-Myers Squibb, Amira
GSK sues Watson Pharma; buys back 1.6 million shares
Bizjournals.com
Monday, July 25, 2011 - 7:35pm
tags:
stock buyback, GSK, Watson Pharmaceuticals, lawsuits, Jalyn, benign prostatic hyperplasia
Whistleblower Lawsuit Against Amgen Is Reinstated
Pharmalot
Monday, July 25, 2011 - 1:38pm
tags:
Amgen, whistleblower lawsuits, kickbacks, False Claims Act, Medicaid, Medicare
Watson Pharmaceuticals Earnings Preview
Benzinga
Monday, July 25, 2011 - 1:36pm
tags:
Watson Pharmaceuticals, earnings
EnVivo, Backed by Fidelity Biosciences, Tests New Weapon Against Alzheimer’s
Xconomy
Monday, July 25, 2011 - 1:32pm
tags:
EnVivo, Fidelity Biosciences, Alzheimer's disease, EVP-0962
Drug prices to plummet in wave of expiring patents
Yahoo/AP
Monday, July 25, 2011 - 1:29pm
tags:
drug prices, patents, generics
Human Genome Incurs Wider Loss
Yahoo/Zacks.com
Monday, July 25, 2011 - 1:27pm
tags:
Human Genome Sciences, earnings
Will pharma fight the Express-Medco deal?
Fierce Pharma
Monday, July 25, 2011 - 12:02pm
tags:
Express Scripts, Medco, M&A, PBMs
Bristol-Myers Squibb Co. Second Quarter Earnings Sneak Peek
Yahoo/Wall St. Cheat Sheet
Monday, July 25, 2011 - 11:53am
tags:
earnings, Bristol-Myers Squibb
4-Star Stocks Poised to Pop: Amarin
Motley Fool
Monday, July 25, 2011 - 10:51am
tags:
Amarin

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.